It was identified through a medicinal chemistry programme at the University of Texas Health Science Center as the lead NNMT inhibitor candidate among a series of 1-methylquinolinium analogues bearing primary amine substitutions, selected for its combination of high passive membrane permeability (confirmed in PAMPA assays), high active transport membrane permeability (confirmed in bidirectional Caco-2 cell assays), potent NNMT inhibitory activity, and high selectivity including confirmed absence of inhibitory effects on related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway
whether hormonal, metabolic, or lifestyle-related
Proper storage after delivery is equally important to maintaining the stability and usability of the compound throughout your study period
Product Details BPC-157, Research Compound (10 mg) Available Sizes & Pricing 10 mg vial, $49.99 Multi-vial pack pricing is available at checkout: Trio (3 vials, 5% off), Half Kit (5 vials, 10% off), and Full Kit (10 vials, 20% off)
Stable Gastric Pentadecapeptide BPC 157Possible Novel Therapy of Glaucoma and Other Ocular Conditions
Michele K